Applied dna linea™ covid-19 assay kit demonstrates effectiveness with detection of multiple sars-cov-2 variants during recent surveillance testing

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc. (nasdaq: apdn) (the “company”), a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced that its linea™ covid-19 assay kit (the “assay kit”) identified covid-19 positive samples that are variants distinct from the wild-type virus that has dominated the u.s. in the pandemic until now. the variants were identified as part of the company's safecircletm pooled surveillance testing service, which is powered b
APDN Ratings Summary
APDN Quant Ranking